Available 7 Days/Week       MON - FRI  8am - 7pm       SAT - SUN  10am – 6pm
Call us (813) 771-0400
Apply Now
  • Home
  • AP
  • Leading Health Industry Infection Clostridioides difficile Symposium Focuses on Patients, Families, and Caregivers

Leading Health Industry Infection Clostridioides difficile Symposium Focuses on Patients, Families, and Caregivers

TAMPA, Fla. /Florida Newswire/ — C Diff Foundation announced today that the Inaugural Patient, Family, and Caregiver C. diff. Live Virtual Symposium will be hosted on November 23, 2020 at 1 p.m.-4 p.m. EST with keynote topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. The event is complimentary with online registration http://www.cdifffoundation.org/

C. diff. Community Symposium
Presenters will deliver data and discuss critical information for an audience of individuals diagnosed and recovering from a C. difficile infection. The symposium was developed to increase awareness, expand the knowledge, and elevate advocacy skills through presentations focused on a leading Healthcare-Associated Infection (HAI) Clostridioides difficile Prevention, Treatments, Clinical Trials, Diagnostics, and Environmental Safety for Adults and Children.

C Diff Foundation expresses their gratitude to Seres Therapeutics for being the Sponsor of the Patient and Family Symposium and for partnering with the C Diff Foundation raising C. diff. awareness.

Seres Therapeutics partners with the C Diff Foundation to support this important event focused on the patients and their families who are so deeply affected by this devastating infection.

The C diff Foundation’s Founding President, Executive Director, Nancy C. Caralla, a three-time C. diff. Survivor, devotes countless hours day in and day out with the members of the C Diff Foundation. As a global resource, the members of the C Diff Foundation are doing all that they can to support the educational needs of patients worldwide. It is through episodes on C. diff. Spores and More live broadcasts, the annual Symposium, and Conference that give a voice to the patients who have suffered through multiple recurrences by including these speakers in the section of the program entitled “Survivor’s Journey.” Only through the patient’s eyes can we begin to truly understand their experiences, and the unmet needs.

About Clostridioides Difficile Infection (CDI)

Clostridioides (formerly Clostridium) difficile, also known as C. difficile or C. diff., is one of the most common causes of healthcare-associated infections in U.S. hospitals (Lessa, et al, 2015, New England Journal of Medicine). Recent estimates suggest C. difficile approaches 500,000 infections annually in the United States and is associated with approximately 20,000 deaths. (Guh, 2020, New England Journal of Medicine). Based on internal estimates including a recurrence rate of approximately 20%, we believe the annual incidence in the U.S. approaches 600,000.

About Seres Therapeutics:

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.

About C Diff Foundation:

C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals is dedicated at supporting public health through education and advocating for Clostridioides difficile infection (CDI) prevention, treatments, clinical trials, AMR, Microbiome, and environmental safety worldwide.

Listen to “C.diff. Spores and More” Tuesdays at 1 p.m. EST (www.cdiffradio.com) sponsored by Clorox Healthcare.

Learn more at: https://cdifffoundation.org/.

Follow C Diff Foundation on LinkedIn, Twitter, Facebook

Twitter @cdiffFoundation #Cdiffpatientsfamily2020

The post Leading Health Industry Infection Clostridioides difficile Symposium Focuses on Patients, Families, and Caregivers appeared first on Florida Newswire.

View Original Post atTampa – Florida Newswire

#tampabaymortgage #tampbaymortgagerates #tampamortgage #tampamortgagerates, AP, Business, C Diff Foundation, C diff Infection, Clostridioides difficile Symposium, Featured, Fla., Florida Business, FLORIDA NEWS, Health and Medical, Non-Profit News, NonProfit and Charities, Product Launches, Seres Therapeutics, Tampa, Tampa Business, Virtual Events

tampa bay mortgage, tampa mortgage, mortgage tampa bay, tampa mortgage rates

*Assumes 2.799% APR, 20% down payment, and conforming 30-year fixed rate first mortgage on a single family, primary residence. The monthly payment you enter includes only principal and interest. Additional required amounts such as taxes, insurance, home owner association dues, assessments, mortgage insurance premiums, flood insurance or other such required payments should also be considered. Not all individuals will qualify for a mortgage loan based on the payment entered. Rates cited are for instructional purposes only; current rates are subject to change at any time without notice.  **Posted APR is based on Mortgage Assumptions
Copyright © 2021 Fidelity Home Group supports Equal Housing Opportunity | All Right Reserved  | NMLS Identifier 1834853. Fidelity Home Group is not affiliated with the Department of Housing and Urban Development (HUD) or the Federal Housing Administration (FHA). Not intended for legal or financial advice, consult your own professionals if such advice is sought. Accessibility Statement  | Consent to Receive Electronic Loan Documents  |  Cookies Policy   |  Disclosures  | Email and Mobile PolicyFair Lending Policy  |  Mortgage Assumptions  |  NMLS Consumer Access  |  Privacy Policy  |  Terms of Use 

tampa bay mortgage, tampa bay mortgage rates, tampa bay mortgage lender, tampa bay mortgage broker, tampa bay mortgage calculator, tampa mortgage, tampa mortgage rates, tampa mortgage lender, tampa mortgage broker, tampa mortgage calculator, mortgage broker near me,